Biorasi Welcomes Nephrologist Dr. Jamie Dwyer to Scientific Advisory Board

July 1, 2021 13:30 UTC

 

 
 

MIAMI--(BUSINESS WIRE)-- bioRASI, a leading global, full-service contract research organization (CRO), is proud to announce the appointment of Jamie P. Dwyer, MD to the position of Scientific Advisory Board (SAB) member. In this role, Dr. Dwyer will provide clinical expertise and leadership for nephrology clinical studies and related areas at Biorasi.

“Adding Dr. Dwyer to our SAB knowledge base is a major step forward,” said Marc Gas, PhD, Head of the Nephrology Center of Excellence and Associate Director of Program Development at Biorasi. “It allows us to continue to deliver the quality that our partners expect in their clinical trials and drive therapies to patients faster.”

Dr. Dwyer is a Professor of Medicine in the Division of Nephrology and Hypertension and Director of the Nephrology Clinical Trials Center at Vanderbilt University Medical Center. He is also the current Chair of the Board, President, and Principal Investigator of the Collaborative Study Group, an international academic research organization.

Dr. Dwyer is a practicing clinical nephrologist who sees patients across the full spectrum of kidney disease, and has served on multiple executive and steering committees for large trials, particularly in CKD progression and cardiovascular outcomes. Dr. Dwyer holds an MD with distinction from Brown University Medical School and has trained in Internal Medicine at Mayo Clinic Florida, and Nephrology and Clinical Research at Vanderbilt.

Dr. Dwyer is one of five SAB members that have joined Biorasi in 2021. This esteemed group of clinicians and researchers includes experts in the fields of nephrology, hematology, oncology, dermatology, and neurology, working together with Biorasi’s Board of Directors and company leadership.

“What impresses me about Biorasi is their dedication to speed and flexibility in nephrology clinical research,” said Dr. Dwyer. “I am looking forward to my new role as an advisor to Biorasi as it continues to make great strides in the design and conduct of clinical trials.”

About Biorasi

Biorasi is a customer-focused, full-service, contract research organization (CRO) that delivers fast and flexible solutions across global clinical trials to maximize speed-to-market for its sponsors. As a leader in neurology, nephrology, dermatology, and the rare and urgent disease market, Biorasi sets new benchmarks for speed, agility, and quality in patient enrollment, decentralized trials, and data transparency. Contact Biorasi at info@biorasi.com / (786) 388-0700.

Contacts

Adam Gottlieb (954) 410-3654 agottlieb@biorasi.com

 
 

Source: Biorasi

Back to news